The cost-effectiveness of Ustekinumab in moderate to severely active crohn’s disease in Sweden
Authors:
Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L
Publication type:
Poster PGI17
Conference name:
20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress
Citation:
Hansson-Hedblom A, Almond C, Borgström F, Sly I, Enkusson D, Troelsgaard Buchholt A and Karlsson L. The cost-effectiveness of Ustekinumab in moderate to severely active crohn’s disease in Sweden. 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Glasgow, Scotland. 4-8 November. Poster PGI17.
